Teng Beina, Lukasz Alexander, Schiffer Mario
Division of Nephrology, Department of Medicine, Medical School Hannover, 30625 Hannover, Germany.
Int J Cell Biol. 2012;2012:320531. doi: 10.1155/2012/320531. Epub 2011 Nov 30.
ADF/cofilins are the major regulators of actin dynamics in mammalian cells. The activation of ADF/cofilins is controlled by a variety of regulatory mechanisms. Dysregulation of ADF/cofilin may result in loss of a precisely organized actin cytoskeletal architecture and can reduce podocyte migration and motility. Recent studies suggest that cofilin-1 can be regulated through several extracellular signals and slit diaphragm proteins. Cofilin knockdown and knockout animal models show dysfunction of glomerular barrier and filtration with foot process effacement and loss of secondary foot processes. This indicates that cofilin-1 is necessary for modulating actin dynamics in podocytes. Podocyte alterations in actin architecture may initiate or aid the progression of a large variety of glomerular diseases, and cofilin activity is required for reorganization of an intact filtration barrier. Since almost all proteinuric diseases result from a similar phenotype with effacement of the foot processes, we propose that cofilin-1 is at the centre stage of the development of proteinuria and thus may be an attractive drug target for antiproteinuric treatment strategies.
ADF/丝切蛋白是哺乳动物细胞中肌动蛋白动力学的主要调节因子。ADF/丝切蛋白的激活受多种调节机制控制。ADF/丝切蛋白的失调可能导致精确组织的肌动蛋白细胞骨架结构丧失,并会降低足细胞的迁移和运动能力。最近的研究表明,丝切蛋白-1可通过多种细胞外信号和裂孔隔膜蛋白进行调节。丝切蛋白基因敲低和基因敲除动物模型显示肾小球屏障和滤过功能障碍,伴有足突消失和次级足突丧失。这表明丝切蛋白-1对于调节足细胞中的肌动蛋白动力学是必需的。肌动蛋白结构的足细胞改变可能引发或促进多种肾小球疾病的进展,完整滤过屏障的重组需要丝切蛋白活性。由于几乎所有蛋白尿性疾病都由足突消失的相似表型引起,我们提出丝切蛋白-1处于蛋白尿发展的中心阶段,因此可能是抗蛋白尿治疗策略中一个有吸引力的药物靶点。